307 related articles for article (PubMed ID: 24658061)
21. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
22. Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.
Maresch J; Birner P; Zakharinov M; Toumangelova-Uzeir K; Natchev S; Guentchev M
Cancer; 2011 Jun; 117(11):2499-504. PubMed ID: 24048798
[TBL] [Abstract][Full Text] [Related]
23. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
Baritaki S; Katsman A; Chatterjee D; Yeung KC; Spandidos DA; Bonavida B
J Immunol; 2007 Oct; 179(8):5441-53. PubMed ID: 17911631
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.
Sun M; Liu C; Nadiminty N; Lou W; Zhu Y; Yang J; Evans CP; Zhou Q; Gao AC
Prostate; 2012 Jan; 72(1):82-9. PubMed ID: 21538419
[TBL] [Abstract][Full Text] [Related]
25. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC
Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648
[TBL] [Abstract][Full Text] [Related]
26. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.
Gao B; Shen X; Kunos G; Meng Q; Goldberg ID; Rosen EM; Fan S
FEBS Lett; 2001 Jan; 488(3):179-84. PubMed ID: 11163768
[TBL] [Abstract][Full Text] [Related]
27. Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines.
Barton BE; Murphy TF; Shu P; Huang HF; Meyenhofer M; Barton A
Mol Cancer Ther; 2004 Oct; 3(10):1183-91. PubMed ID: 15486184
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.
Kotha A; Sekharam M; Cilenti L; Siddiquee K; Khaled A; Zervos AS; Carter B; Turkson J; Jove R
Mol Cancer Ther; 2006 Mar; 5(3):621-9. PubMed ID: 16546976
[TBL] [Abstract][Full Text] [Related]
29. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
Barton BE; Karras JG; Murphy TF; Barton A; Huang HF
Mol Cancer Ther; 2004 Jan; 3(1):11-20. PubMed ID: 14749471
[TBL] [Abstract][Full Text] [Related]
30. Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3.
Ahmad R; Raina D; Meyer C; Kufe D
Cancer Res; 2008 Apr; 68(8):2920-6. PubMed ID: 18413761
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
[TBL] [Abstract][Full Text] [Related]
32. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
[TBL] [Abstract][Full Text] [Related]
33. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
Chun J; Li RJ; Cheng MS; Kim YS
Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
[TBL] [Abstract][Full Text] [Related]
34. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
Hahm ER; Singh SV
Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
36. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
37. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
Zhao Q; Bi Y; Zhong J; Li X; Guo J; Liu YX; Pan LR; Tan Y; Deng ZS; Yu XJ
Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
39. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
Sen B; Saigal B; Parikh N; Gallick G; Johnson FM
Cancer Res; 2009 Mar; 69(5):1958-65. PubMed ID: 19223541
[TBL] [Abstract][Full Text] [Related]
40. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.
Jorvig JE; Chakraborty A
Anticancer Drugs; 2015 Feb; 26(2):160-6. PubMed ID: 25243457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
